FacebookTweetLinkedInPrint Two remarkable men from Donegal are setting out to walk 100km across the county in a single day, ...

Trials have shown abiraterone can stop prostate cancer from spreading and it can extend the lives of those with the disease.

In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

Erectile dysfunction is common after prostate cancer treatment. A new study shows that aerobic exercise and strength training ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

Sponsored by City Of Hope Cancer Center Prostate cancer is the second-most common cancer among men in the U.S., it’s ...